Article
Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
22 Aug 2019
Abstract excerpt
BACKGROUND: Activation of Wnt/β-catenin pathway is a frequent event in hepatocellular carcinoma and is associated with enhanced cell survival and proliferation. Therefore, targeting this signaling pathway is discussed as an attractive therapeutic approach for HCC treatment. BCL9 and BCL9L, two homologous coactivators of the β-catenin transcription factor complex, have not yet been comprehensively characterized in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
